miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisRihan El Bezawy, Paolo Gandellini, Denis Cominetti et al.|Cancer Letters|2017Cited by 96
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cellsNoemi Arrighetti, Laura Gatti, Loris De Cecco et al.|Toxicology and Applied Pharmacology|2016Cited by 48
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination TherapyYaniv Kazansky, Alex Kentsis, Daniel Cameron et al.|Cancer Discovery|2024Cited by 47
Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cellsGiacomo Cossa, Paola Perego, Cinzia Lanzi et al.|Cancer Letters|2014Cited by 37
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Paola Perego, Alexandra Sevko et al.|Oncotarget|2014Cited by 30